Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122712) titled 'Induction Therapy With Anti Thymocyte Immunoglobulin in Liver transplantation for Patients With Liver Cancer Who Received Preoperative PD-1 inhibitor: A Multicenter, Prospective, Randomized Controlled Study' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
hepatocellular carcinoma
Intervention:
Control group:Baliximab drugs as immune induction agents
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-09-04
Target Sample Size: Control group:52;Research Group:52;...